This is particularly evident in the Alzheimer’s disease pathway, where key genes involved in amyloid processing and tau protein pathology, such as APP and MAPT, exhibit significant increases in expression. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.